Medicament carriers in the form of film having active substance incorporated therein

Claim 2

In a pharmaceutical composition in unit dosage form for enteral or topical administration and comprising a safe and a pharmaceutically effective amount of an active medicament compound and a flexible, water soluble film carrier therefor, the improvement wherein: the medicament is dissolved or uniformly suspended in a film carrier consisting essentially of a non-ionic, water soluble methyl ether or hydroxyalkyl ether of cellulose and the pharmaceutical composition is in the form of a tissue-like sheet, having a uniform dry film thickness of about 0.05-1 mm., drawn from a solution of the film carrier containing 0-30% by weight of a filler and up to 60% by weight of the film carrier of the medicament.

Claim 3

A composition according to claim 1, wherein the film carrier is hydroxypropyl-cellulose, hydroxyethyl-cellulose, methylhydroxypropyl-cellulose or a mixture thereof.

Claim 4

A composition according to claim 1, wherein the medicament is an estrogen, gestagen or admixture thereof.

Claim 5

A composition according to claim 1, wherein the release agent is a polyoxethylene-polyoxypropylene copolymer, a polyoxylstearate or an alkyl- or alkanoyl-substituted polyaddition product of ethylene oxide.

Claim 6

A composition according to claim 1 wherein the medicament or concentration thereof differs in areas thereof defined by strips adjacent to one another along the width of the sheet.

Claim 7

A composition according to claim 5, wherein the strips are identified by different dyestuffs.

Claim 8

A composition according to claim 1, wherein the sheet is perforated to provide a plurality of single-unit dosages.

Claim 9

A composition according to claim 1, wherein the sheet is a transparent and smooth film.

Claim 10

A composition according to claim 1 containing a water-insoluble filler uniformly suspended in the film carrier and the film is paper-like.

Claim 11

A composition according to claim 9, wherein the filler is cellulose.

Claim 12

A composition according to claim 1, wherein the film carrier is methyl cellulose.

Claim 13

A composition according to claim 1, wherein the sheet has a thickness of 0.07-0.3 mm.

Claim 14

A composition according to claim 1, wherein the film carrier is hydroxypropyl-cellulose, hydroxyethyl-cellulose, methylhydroxypropyl-cellulose or a mixture thereof; the medicament is an estrogen, gestagen or admixture thereof; the release agent is a polyoxethylene-polyoxypropylene copolymer, a polyoxyl stearate or an alkyl- or alkanoyl-substituted polyaddition product of ethylene oxide; and the sheet has a thickness of 0.07-0.3 mm.

Claim 15

A pharmaceutical composition in unit dosage form for enteral or topical administration and comprising a safe and a pharmaceutically effective amount of an active medicament compound and a flexible, water soluble film carrier therefor, prepared by a process which comprises: (a) drawing into a sheet having a uniform layer thickness of about 0.1-2 mm and a dry thickness of about 0.05-1 mm, a homogeneous solution or suspension consisting essentially of (1) up to 60% by weight, based on the film carrier, of the medicament, (2) 0-30% by weight of a pharmaceutically acceptable filler, (3) a film-forming amount of a water-soluble film-forming polymer, and (4) as solvent or suspending medium, one or both of water and an organic volatile solvent system comprising an organic polar solvent miscible in water; and (b) drying the thus-formed sheet to remove the solvent or suspending medium therefrom.

Claim 16

A pharmaceutical composition in unit dosage form for enteral or topical administration and comprising a safe and a pharmaceutically effective amount of an active medicament compound and a flexible, water soluble film carrier therefor, prepared by a process which comprises: (a) drawing into a sheet having a uniform layer thickness of about 0.1-2 mm and a dry thickness of about 0.05-1 mm, a homogeneous solution or suspension consisting essentially of (1) up to 60% by weight, based on the film carrier, of the medicament, (2) 0-30% by weight of a pharmaceutically acceptable filler, (3) a film-forming amount of a water-soluble film-forming polymer, and (4) as solvent or suspending medium, one or both of water and an organic volatile solvent system comprising an organic polar solvent miscible in water; and (b) drying the thus-formed sheet to remove the solvent or suspending medium therefrom.

Claim 17

The pharmaceutical composition of claim 14, wherein the homogeneous solution or suspension additionally contains about 0.01-2% by weight of a pharmaceutically acceptable release agent.

Claim 18

The pharmaceutical composition of claim 1 wherein the solution of the film carrier additionally contains 0.01-2% by weight of a pharmaceutically acceptable release agent.